La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Biophytis a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Biophytis..

Biophytis (OTC:BPTSY) Azioni, Catena delle Opzioni

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate BIO101, is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis SA

On Tuesday, April 22, U.S. markets closed higher, driven by strong earnings reports and indications of de-escalating U.S.-China trade tensions. President Trump&#8217;s remarks, including backing Fed Chair Powell and signaling tariff cuts following a trade deal, sparked a rally.
The S&amp;P 500 surged 2.5%, with tech giants like Amazon, Nvidia, and Apple leading the gains. However, ongoing trade uncertainties continue to weigh on economic growth projections.
Related: <a target="_blank" href="https://www.benzinga.com/markets/25/04/44942449/trump-pledges-substantial-cut-in-china-tariffs-but-refuses-to-make-it-zero-if-they-dont-make-a-deal-we-will-set-the-deal" rel="noreferrer noopener">Trump Pledges &#8216;Substantial&#8217; Cut In China Tariffs, But Refuses To Make It &#8216;Zero:&#8217; &#8216;If They Don&#8217;t Make A Deal, We Will Set The Deal&#8217;</a>
In economic data, the U.S. Redbook Index increased by 7.4% compared to the same week last year for the week ending April 19. All S&amp;P 500 sectors ended Tuesday with gains, led by financial, consumer discretionary, and communication services stocks.
The Dow Jones Industrial Average gained 2.66% to 39,186.98, the S&amp;P 500 rose 2.51% to 5,287.76, and the Nasdaq Composite closed 2.71% higher at 16,300.42.
Asia Markets Today
<ul>
<li>On Wednesday, Japan&#8217;s Nikkei 225 gained 2.02% to close at 34,911.00, gains in the Real Estate, Banking, and Textile sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 closed higher by 1.33% at 7,920.50, led by gains in the Energy, IT, and Industrials sectors.</li>
<li>India&#8217;s Nifty 50 was up 0.67% at 24,328.95, and the Nifty 500 rose 0.58% to 22,213.60.</li>
<li>China&#8217;s Shanghai Composite slid 0.10% to 3,296.36, while Shanghai Shenzhen CSI 300 rose 0.08% to 3,786.88.</li>
<li>Hong Kong&#8217;s Hang Seng closed 2.7% higher at 22,072.62.</li>
</ul>
Eurozone at 06:00 AM ET
<ul>
<li>The European STOXX 50 was up 2.47%.</li>
<li>Germany&#8217;s DAX gained 2.74%.</li>
<li>France&#8217;s CAC 40 rose 2.29%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 1.29%.</li>
</ul>
Commodities at 06:00 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.35% at $64.53/bbl, and Brent was up 1.26% at $68.29/bbl.</li>
<li>Oil prices rose, fueled by U.S. sanctions on Iran, a drop in crude stocks, and President Trump&#8217;s softer stance on tariffs and the Federal Reserve. Brent crude hit $68.54 per barrel.</li>
<li>Natural Gas rose 1.40% to $3.049.</li>
<li>Gold was trading lower by 2.39% at $3,337.34, Silver was down 0.14% to $32.855, and Copper rose 0.17% to $4.8885.</li>
<li>Gold prices fell on Wednesday as U.S. President Trump hinted at lower trade tariffs on China and backtracked on his criticism of the Federal Reserve.</li>
</ul>
U.S. Futures at 06:00 AM ET
<ul>
<li>Dow futures were up 1.62%, S&amp;P 500 futures gained 2.11%, and Nasdaq 100 futures rose 2.51%.</li>
<li>U.S. stock index futures surged Wednesday, building on Tuesday&#8217;s gains, driven by less hawkish comments from President Trump on the Federal Reserve and China</li>
</ul>
Forex at 06:00 AM ET
<ul>
<li>The U.S. dollar index gained 0.11% to 99.09, the USD/JPY rose 0.28% to 141.93, and the USD/AUD slid 0.71% to 1.5600.</li>
<li>The U.S. dollar steadied on Wednesday, supported by hopes of de-escalating trade tensions and President Trump&#8217;s backing away from threats to fire Federal Reserve Chair Jerome Powell.</li>
</ul>
Image via Shutterstock

Asia

News

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Gain, Gold Slides As Trump Signals Potential Trade Relief - Global Markets Today While US Slept

Needham analyst Ryan Koontz reiterates Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Buy and maintains $53 price target.

Price Target

Reiteration

Analyst Ratings

CALX

Needham Reiterates Buy on Calix, Maintains $53 Price Target

D. Boral Capital analyst Jesse Sobelson initiates coverage on United States Antimony (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#AMEX">UAMY</a>) with a Buy rating and announces Price Target of $5.

Initiation

UAMY

D. Boral Capital Initiates Coverage On United States Antimony with Buy Rating, Announces Price Target of $5

D. Boral Capital analyst Jason Kolbert maintains ImmunityBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) with a Buy and maintains $30 price target.

IBRX

D. Boral Capital Maintains Buy on ImmunityBio, Maintains $30 Price Target

Needham analyst Kyle Peterson reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $295 price target.

Needham Reiterates Buy on Equifax, Maintains $295 Price Target

Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) lowers FY2025 GAAP EPS guidance from $12.40-$13.40 to $12.15-$12.90 vs $12.19 analyst estimate. Lowers FY2025 sales outlook from $12.90 billion to $12.76 billion vs $12.95 billion estimate.

Guidance

Ryder System Lowers FY2025 GAAP EPS Guidance from $12.40-$13.40 to $12.15-$12.90 vs $12.19 Est; Revenue for 2025 FY is expected to up by 1% YoY

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) with a Buy and maintains $11 price target.

CERO

D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $11 Price Target

Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) is looking for Q2 GAAP EPS of $2.85-$3.10 vs $3.18 analyst estimate..

Ryder System Sees Q2 GAAP EPS $2.85-$3.10 vs $3.18 Est

Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) is looking for Q2 Adj EPS of $3.00-$3.25 vs $3.31 analyst estimate..

Ryder System Sees Q2 Adj EPS $3.00-$3.25 vs $3.31 Est

Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) lowers FY2025 Adj EPS guidance from $13.00-$14.00 to $12.85-$13.60 vs $13.17 analyst estimate. Lowers FY2025 sales outlook from $10.50 billion to $10.37 billion vs $12.95 billion estimate.

Ryder System Lowers FY2025 Adj EPS Guidance from $13.00-$14.00 to $12.85-$13.60 vs $13.17 Est; Operating Revenue for 2025 FY is expected to up by 1% YoY

Philip Morris Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>) is looking for Q2 Adj EPS of $1.80-$1.85 vs $1.80 analyst estimate..

Philip Morris Intl Sees Q2 Adj EPS $1.80-$1.85 vs $1.80 Est

Needham analyst John Todaro reiterates Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Buy and maintains $10 price target.

APLD

Needham Reiterates Buy on Applied Digital, Maintains $10 Price Target

Funding to Accelerate Development of Low-Cost Photodetectors Applicable to Mobile, AR/VR, and Industrial Markets
GOLETA, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / April 23, 2025 / Aeluma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALMU#NASDAQ">ALMU</a>), a semiconductor company specializing in high-performance, scalable technologies for mobile, automotive, AI, defense and aerospace, communication, and quantum computing, announced today it has received a contract from the U.S. Department of Energy (DOE) to develop commercially viable, low-cost shortwave infrared (SWIR) photodetectors. The award will accelerate commercialization of Aeluma's wafer-scale platform for high-sensitivity, energy-efficient photodetector sensors applicable across critical growth sectors.
The DOE-backed project targets development of a breakthrough solution for SWIR detection-supporting wavelengths beyond the visible spectrum that are critical for applications in quality inspection, remote sensing, and machine vision. SWIR is also eye safe, enabling high-performance systems in consumer markets including mobile, AR/VR, and automotive.

Contracts

ALMU

Aeluma Secures Contract From U.S. DoE To Develop Commercially Viable, Low-cost Shortwave Infrared Photodetectors

TSLA: 7% &#x7C; <a href="https://www.benzinga.com//node/44939207">Tesla shares are trading higher following Q1 financial results.</a>
&nbsp;
OKLO: -13% &#x7C; <a href="https://www.benzinga.com//node/44936586">‘Sam Altman Steps Down As Oklo Board Chair, Freeing Nuclear Startup To Work With More AI Companies'</a>
&nbsp;
INTC: 4% &#x7C; <a href="https://www.benzinga.com//node/44944858">Intel shares are trading higher following a report indicating the company plans to cut over 20% of its workforce as part of a restructuring.</a>

Movers

Trading Ideas

INTC

OKLO

TSLA

Market-Moving News for April 23rd

NioCorp Is Launching A Limited 9-hole Drilling Campaign Later This Month To Support The Conversion Of A Portion Of Its Current Indicated Resources Into Measured Resources And The Subsequent Conversion Of A Portion Of Its Current Probable Mineral Reserves Into Proven Mineral Reserves At Its Nebraska-based Elk Creek Critical Minerals Project

TLRY

Tilray's Breckenridge Distillery Unveils Cognac Cask Finish Whiskey, Plans U.S. Expansion

Barclays analyst Betty Jiang upgrades Sitio Royalties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STR#NYSE">STR</a>) from Underweight to Equal-Weight and lowers the price target from $23 to $21.

Upgrades

Barclays Upgrades Sitio Royalties to Equal-Weight, Lowers Price Target to $21

MCHP

Microchip Technology Releases New Microcontroller With Integrated Low-Power Peripherals And The Ability To Precisely Measure Volatile Analog Signals

<ul>
<li>GXO to manage four additional brands in the Eindhoven site</li>
<li>New contract brings longstanding partnership to more than a decade</li>
</ul>

Comments

Biophytis

Biophytis (BPTSY) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO